Hutch News

Hutch News

Stories tagged 'new england journal of medicine'

Appelbaum editorial: Evidence tips transplant practice back to bone marrow

In New England Journal of Medicine editorial, Fred Hutchinson Cancer Research Center’s Dr. Fred Appelbaum argues adult stem cells harvested from bone marrow rather than blood of unrelated donors are best for reducing graft-vs.-host disease risk

Oct. 22, 2012 | By Dean Forbes

View story >

Patient's cloned T cells kill tumors

Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission

June 23, 2008 | By Dean Forbes

Scientists from Fred Hutchinson Cancer Research Center describe the first successful use of a human patient’s cloned infection-fighting T-cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission

View story >

The troubling global trend for breast cancer

With greater affluence comes a global increase in breast-cancer risk, reports cancer biology researcher Peggy Porter

Jan. 28, 2008

As Dr. Peggy Porter from Fred Hutchinson Cancer Research Center reports in her Jan. 17, New England Journal of Medicine “Perspective,” the most widely cited reasons for the global rise of breast-cancer incidences and related deaths are increasing prosperity and the “Westernization” of traditional lifestyles.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.